Cited by 1,924Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyAbdominal Surgery and Complications

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Open access

Russell, James A., Walley, Keith R., Singer, Joel, Gordon, Anthony C., Hébert, Paul C., Cooper, D. James, Holmes, Cheryl L., Mehta, Sangeeta, Granton, John T., Storms, Michelle M., Cook, Deborah J., Presneill, Jeffrey J., Ayers, Dieter·2008·New England Journal of Medicine

DOI 10.1056/nejmoa067373

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as compared with norepinephrine would decrease mortality among patients with septic shock who were being treated with conventional (catecholamine) vasopressors. METHODS: In this multicenter, randomized, double-blind trial, we assigned patients who had septic shock and were receiving a minimum of 5 microg of norepinephrine per minute to receive either low-dose vasopressin (0.01 to 0.03 U per minute) or norepinephrine (5 to 15 microg per minute) in addition to open-label vasopressors. All vasopressor infusions were titrated and tapered according to protocols to maintain a target blood pressure. The primary end point was the mortality rate 28 days after the start of infusions. RESULTS: A total of 778 patients underwent randomization, were infused with the study drug (396 patients received vasopressin, and 382 norepinephrine), and were included in the analysis. There was no significant difference between the vasopressin and norepinephrine groups in the 28-day mortality rate (35.4% and 39.3%, respectively; P=0.26) or in 90-day mortality (43.9% and 49.6%, respectively; P=0.11). There were no significant differences in the overall rates of serious adverse events (10.3% and 10.5%, respectively; P=1.00). In the prospectively defined stratum of less severe septic shock, the mortality rate was lower in the vasopressin group than in the norepinephrine group at 28 days (26.5% vs. 35.7%, P=0.05); in the stratum of more severe septic shock, there was no significant difference in 28-day mortality (44.0% and 42.5%, respectively; P=0.76). A test for heterogeneity between these two study strata was not significant (P=0.10). CONCLUSIONS: Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were treated with catecholamine vasopressors. (Current Controlled Trials number, ISRCTN94845869 [controlled-trials.com].).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa067373

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
(1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00025 · Cited by 5,134
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310

Show all 36 references

Research works printed but not linked: 2

Argenziano M, 1997, Circulation, 96, II
Chen JM, 1999, Circulation, 100, II

Sorted by citations

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citation
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citation
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
Kellum, J. A., Lameire, N., & for the KDIGO AKI Guideline Work Group (2013) · Critical Care · doi:10.1186/cc11454 · Cited by 2,827
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345
Sepsis and septic shock
Cecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254
Chimeric antigen receptor T-cell therapy—assessment and management of toxicities
Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., Daver, N., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.148 · Cited by 2,438
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
Perner, A., Haase, N., Guttormsen, A. B., Tenhunen, J. J., Klemenzson, G., Åneman, A., Madsen, K. R., Møller, M. H., Elkjær, J. M., Poulsen, L. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204242 · Cited by 1,808
Sepsis and septic shock
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,795
Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012
Kaukonen, K.-M., Bailey, M., Suzuki, S., Pilcher, D., & Bellomo, R. (2014) · JAMA · doi:10.1001/jama.2014.2637 · Cited by 1,459
Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality*
Boyd, J. H., Forbes, J., Nakada, T.-A., Walley, K. R., & Russell, J. A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181feeb15 · Cited by 1,517
Self-citation
Circulatory Shock
Vincent, J., & Backer, D. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208943 · Cited by 1,532
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S. R., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,306
High versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Sepsis associated acute kidney injury
Poston, J. T., & Koyner, J. L. (2019) · BMJ · doi:10.1136/bmj.k4891 · Cited by 917
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup
Zarbock, A., Nadim, M. K., Pickkers, P., Gómez, H., Bell, S., Joannidis, M., KASHANI, K. B., Koyner, J. L., Pannu, N., Meersch, M., et al. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00683-3 · Cited by 875
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial
Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.10485 · Cited by 728
Self-citation
American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock
Davis, A. L., Carcillo, J. A., Aneja, R. K., Deymann, A. J., Lin, J. C., Nguyen, T. C., Okhuysen‐Cawley, R., Relvas, M. S., Rozenfeld, R. A., Skippen, P. W., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002425 · Cited by 689
How to Use a Subgroup Analysis: Users’ Guide to the Medical Literature
Sun, X., Ioannidis, J. P. A., Agoritsas, T., Alba, A. C., & Guyatt, G. (2014) · JAMA · doi:10.1001/jama.2013.285063 · Cited by 550
Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress
Dünser, M. W., & Hasibeder, W. R. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609340519 · Cited by 495
Severe sepsis in cirrhosis†
Gustot, T., Durand, F., Lebrec, D., Vincent, J., & Moreau, R. (2009) · Hepatology · doi:10.1002/hep.23264 · Cited by 445
Sepsis and Septic Shock – Basics of diagnosis, pathophysiology and clinical decision making
Font, M. D., Thyagarajan, B., & Khanna, A. K. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.02.011 · Cited by 452
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 431
Lactic Acidosis in Sepsis: It’s Not All Anaerobic
Suetrong, B., & Walley, K. R. (2015) · CHEST Journal · doi:10.1378/chest.15-1703 · Cited by 429
Self-citation
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Porter, D. L., Frey, N. V., Wood, P. A., Weng, Y., & Grupp, S. A. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0571-y · Cited by 406
Reappraisal of Ventilator-Free Days in Critical Care Research
Yehya, N., Harhay, M. O., Curley, M. A. Q., Schoenfeld, D., & Reeder, R. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-2050cp · Cited by 395
Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review
Price, L., Wort, S. J., Finney, S. J., Marino, P. S., & Brett, S. J. (2010) · Critical Care · doi:10.1186/cc9264 · Cited by 392
Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol.
Puskarich, M. A., Trzeciak, S., Shapiro, N. I., Arnold, R. C., Horton, J. M., Studnek, J. R., Kline, J. A., & Jones, A. E. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e87ab · Cited by 376
Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis
Gordon, A. C., Perkins, G. D., Singer, M., McAuley, D. F., Orme, R. M. L., Santhakumaran, S., Mason, A. J., Cross, M., Al-Beidh, F., Best-Lane, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609409 · Cited by 372
Self-citation
Management of bacterial infections in cirrhosis
Fernández, J., & Gustot, T. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60002-6 · Cited by 382
Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery
Hajjar, L. A., Vincent, J., Galas, F. R. B. G., Rhodes, A., Landoni, G., Osawa, E., Melo, R., Sundin, M., Grande, S. M., Gaiotto, F. A., et al. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001434 · Cited by 372
The Septic Heart
Märtin, L., Derwall, M., Zoubi, S. A., Zechendorf, E., Reuter, D. A., Thiemermann, C., & Schuerholz, T. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.08.1037 · Cited by 371
PCSK9 is a critical regulator of the innate immune response and septic shock outcome
Walley, K. R., Thain, K. R., Russell, J. A., Reilly, M. P., Meyer, N. J., Ferguson, J. F., Christie, J. D., Nakada, T., Fjell, C. D., Thair, S. A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008782 · Cited by 366
Self-citation
Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017
Joannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honoré, P. M., Hoste, E. A. J., Ostermann, M., Straaten, H. M. O., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 356
Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults
The COIITSS Study Investigators* (2010) · JAMA · doi:10.1001/jama.2010.2 · Cited by 343
Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design
Prescott, H. C., Calfee, C. S., Thompson, B., Angus, D. C., & Liu, V. X. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2544cp · Cited by 329
An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: An International Consensus Conference in Intensive Care Medicine
Brochard, L. J., Abroug, F., Brenner, M., Broccard, A. F., Danner, R. L., Ferrer, M., Laghi, F. A., Magder, S. A., Papazian, L., Pelosi, P. P., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1664st · Cited by 322
A review of sepsis-induced cardiomyopathy
Sato, R., & Nasu, M. (2015) · Journal of Intensive Care · doi:10.1186/s40560-015-0112-5 · Cited by 323
AKI Associated with Cardiac Surgery
Thiele, R. H., Isbell, J. M., & Rosner, M. H. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07830814 · Cited by 311
Early versus delayed administration of norepinephrine in patients with septic shock
Bai, X., Yu, W., Wu, J., Lin, Z., Tan, S., Duan, K., Dong, Y., Xu, L., & Li, N. (2014) · Critical Care · doi:10.1186/s13054-014-0532-y · Cited by 303
2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & GIORGIO, R. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 342
Vasopressors for the treatment of septic shock: Systematic review and meta-analysis.
Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., & Grossman, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129305 · Cited by 293
Clinical review: The liver in sepsis
Nesseler, N., Launey, Y., Aninat, C., Morel, F., Mallédant, Y., & Séguin, P. (2012) · Critical Care · doi:10.1186/cc11381 · Cited by 295
Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality
Patel, A., Laffan, M., Waheed, U., & Brett, S. J. (2014) · BMJ · doi:10.1136/bmj.g4561 · Cited by 292
Sepsis-induced Cardiomyopathy
Romero-Bermejo, F. J., Ruiz-Bailén, M., Cebrián, J. G., & Huertos-Ranchal, M. J. (2011) · Current Cardiology Reviews · doi:10.2174/157340311798220494 · Cited by 297
Surviving sepsis campaign: research priorities for sepsis and septic shock
Coopersmith, C. M., Backer, D. D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martín‐Loeches, I., Nunnally, M., Antonelli, M. M., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5175-z · Cited by 292
Association between Source of Infection and Hospital Mortality in Patients Who Have Septic Shock
Leligdowicz, A., Dodek, P., Norena, M., Wong, H., Kumar, A., & Kumar, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201310-1875oc · Cited by 292
Effects of Intraoperative Fluid Management on Postoperative Outcomes
Shin, C. H., Long, D. R., McLean, D. J., Grabitz, S. D., Ladha, K. S., Timm, F. P., Thevathasan, T., Pieretti, A. C., Ferrone, C. R., Hoeft, A., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002220 · Cited by 260
Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
Carr, A. C., Shaw, G. M., Fowler, A. A., & Natarajan, R. (2015) · Critical Care · doi:10.1186/s13054-015-1131-2 · Cited by 263
Fever Control Using External Cooling in Septic Shock: A Randomized Controlled Trial
Schortgen, F., Clabault, K., Katsahian, S., Devaquet, J., Mercat, A., Deye, N., Dellamonica, J., Bouadma, L., Cook, F., Beji, O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1820oc · Cited by 254
The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock*
Jhanji, S., Stirling, S., Patel, N. G., Hinds, C., & Pearse, R. M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a00a1c · Cited by 252
Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study
Schmittinger, C. A., Torgersen, C., Luckner, G., Schröder, D. C. H., Lorenz, I. H., & Dünser, M. W. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2531-2 · Cited by 246
The effects of vasopressin on acute kidney injury in septic shock
Gordon, A. C., Russell, J. A., Walley, K. R., Singer, J., Ayers, D., Storms, M. M., Holmes, C. L., Hébert, P. C., Cooper, D. J., Mehta, S., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1687-x · Cited by 245
Self-citation
Vasoplegia treatments: the past, the present, and the future
Lévy, B., Fritz, C., Tahon, E., Jacquot, A., Auchet, T., & Kimmoun, A. (2018) · Critical Care · doi:10.1186/s13054-018-1967-3 · Cited by 252
A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters
Loubani, O. M., & Green, R. S. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.01.014 · Cited by 235
Part 10: Pediatric Basic and Advanced Life Support
Kleinman, M. E., de Caen, A. R., Chameides, L., Atkins, D. L., Berg, R. A., Berg, M., Bhanji, F., Biarent, D., Bingham, R. M., Coovadia, A. H., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971093 · Cited by 249
Management of Refractory Vasodilatory Shock
Jentzer, J. C., Vallabhajosyula, S., Khanna, A. K., Chawla, L. S., Busse, L. W., & KASHANI, K. B. (2018) · CHEST Journal · doi:10.1016/j.chest.2017.12.021 · Cited by 241
Subphenotypes in critical care: translation into clinical practice
Reddy, K., Sinha, P., O’Kane, C. M., Gordon, A. C., Calfee, C. S., & McAuley, D. F. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30124-7 · Cited by 238
Self-citation
Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial
Dünser, M. W., Ruokonen, E., Pettilä, V., Ulmer, H., Torgersen, C., Schmittinger, C. A., Jakob, S. M., & Takala, J. A. (2009) · Critical Care · doi:10.1186/cc8167 · Cited by 239
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials
Sinha, P., Kerchberger, V. E., Willmore, A., Chambers, J., Zhuo, H., Abbott, J. A., Jones, C., Wickersham, N. E., Wu, N., Neyton, L. P. A., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00237-0 · Cited by 235
Self-citation
Sepsis and septic shock: Guideline-based management
Dugar, S. P., Choudhary, C., & Duggal, A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.18143 · Cited by 248
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock*
Russell, J. A., Walley, K. R., Gordon, A. C., Cooper, D. J., Hébert, P. C., Singer, J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961ace · Cited by 230
Self-citation
Vasopressor therapy in critically ill patients with shock
Russell, J. A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05801-z · Cited by 247
Self-citation
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis
McIntyre, W. F., Um, K. J., Alhazzani, W., Lengyel, A. P., Hajjar, L., Gordon, A. C., Lamontagne, F., Healey, J. S., Whitlock, R. P., & Belley-Côté, E. P. (2018) · JAMA · doi:10.1001/jama.2018.4528 · Cited by 225
Self-citation
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020)
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 232
Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
Busse, L. W., Barker, N. A., & Petersen, C. (2020) · Critical Care · doi:10.1186/s13054-020-2743-8 · Cited by 242
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
Morelli, A., Ertmer, C., Rehberg, S. W., Lange, M., Orecchioni, A., Cecchini, V., Bachetoni, A., D’Alessandro, M., Aken, H. V., Pietropaoli, P., et al. (2009) · Critical Care · doi:10.1186/cc7990 · Cited by 224
Normal-Range Blood Lactate Concentration in Septic Shock Is Prognostic and Predictive
Wacharasint, P., Nakada, T., Boyd, J. H., Russell, J. A., & Walley, K. R. (2012) · Shock · doi:10.1097/shk.0b013e318254d41a · Cited by 220
Self-citation
Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside
Lévy, B., Collin, S., Sennoun, N., Ducrocq, N., Kimmoun, A., Asfar, P., Perez, P., & Meziani, F. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-2045-8 · Cited by 238
Sepsis: mechanisms of bacterial injury to the patient
Minasyan, H. A. (2019) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-019-0596-4 · Cited by 235
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · CHEST Journal · doi:10.1378/chest.12-1106 · Cited by 211
Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury
Liu, K. D., Levitt, J. E., Zhuo, H., Kallet, R. H., Brady, S. E., Steingrub, J. S., Tidswell, M., Siegel, M. D., Soto, G. J., Peterson, M. W., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-419oc · Cited by 206
Vasoactive Drugs in Circulatory Shock
Hollenberg, S. M. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0972ci · Cited by 230
Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy
Bhatraju, P. K., Zelnick, L. R., Herting, J. R., Katz, R., Mikacenic, C. R., Harju-Baker, S., Morrell, E. D., Robinson‐Cohen, C., Calfee, C. S., Christie, J. D., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1346oc · Cited by 215
Self-citation
Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study
Arabi, Y. M., Dara, S. I., Tamim, H., Rishu, A. H., Bouchama, A., Khedr, M., Feinstein, D., Parrillo, J. E., Wood, K. E., Keenan, S., et al. (2013) · Critical Care · doi:10.1186/cc12680 · Cited by 205
Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study
Chawla, L. S., Busse, L., Brasha-Mitchell, E., Davison, D., Honiq, J., Alotaibi, Z., & Seneff, M. G. (2014) · Critical Care · doi:10.1186/s13054-014-0534-9 · Cited by 197
Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit
Jentzer, J. C., Coons, J. C., Link, C. B., & Schmidhofer, M. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414559838 · Cited by 201
Use of inotropes and vasopressor agents in critically ill patients
Bangash, M. N., Kong, M., & Pearse, R. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01588.x · Cited by 196
Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study
Rautanen, A., Mills, T. C., Gordon, A. C., Hutton, P., Steffens, M., Nuamah, R. A., Chiche, J., Parks, T., Chapman, S. J., Davenport, E. E., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70290-5 · Cited by 211
Self-citation
Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study
Poukkanen, M., Wilkman, E., Vaara, S. T., Pettilä, V., Kaukonen, K., Korhonen, A., Uusaro, A. V., Hovilehto, S., Inkinen, O., Laru‐Sompa, R., et al. (2013) · Critical Care · doi:10.1186/cc13161 · Cited by 196
Sepsis and septic shock: current approaches to management
Thompson, K., Venkatesh, B., & Finfer, S. R. (2019) · Internal Medicine Journal · doi:10.1111/imj.14199 · Cited by 207
Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis
Iglesias, J. I., Vassallo, A. V., Patel, V. V., Sullivan, J., Cavanaugh, J., & Elbaga, Y. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.049 · Cited by 195
Vasoplegia After Cardiovascular Procedures—Pathophysiology and Targeted Therapy
Shaefi, S., Mittel, A. M., Klick, J. C., Evans, A. S., Ivascu, N. S., Gutsche, J. T., & Augoustides, J. G. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.10.032 · Cited by 189
We should abandon randomized controlled trials in the intensive care unit
Vincent, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f208ac · Cited by 190
Sepsis‐induced acute kidney injury: A disease of the microcirculation
Ma, S., Evans, R. G., Iguchi, N., Tare, M., Parkington, H. C., Bellomo, R., May, C. N., & Lankadeva, Y. R. (2018) · Microcirculation · doi:10.1111/micc.12483 · Cited by 189
A plea for personalization of the hemodynamic management of septic shock
Backer, D. D., Cecconi, M., Chew, M. S., Hajjar, L. A., Monnet, X., Ospina-Tascón, G. A., Ostermann, M., Pinsky, M. R., & Vincent, J. (2022) · Critical Care · doi:10.1186/s13054-022-04255-y · Cited by 187
Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum
Andreis, D. T., & Singer, M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4249-z · Cited by 185
Bench-to-bedside review: Vasopressin in the management of septic shock
Russell, J. A. (2009) · Critical Care · doi:10.1186/cc8224 · Cited by 176
Self-citation
Prevention of acute kidney injury and protection of renal function in the intensive care unit
Joannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honoré, P. M., Straaten, H. M. O., Ronco, C., Schetz, M. R. C., & Woittiez, A. J. J. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1678-y · Cited by 177
The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials
Belletti, A., Castro, M. L., Silvetti, S., Greco, T., Biondi‐Zoccai, G., Pasin, L., Zangrillo, A., & Landoni, G. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev284 · Cited by 173
Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis
Stolk, R. F., van der Pasch, E., Naumann, F. V., Schouwstra, J., Bressers, S., van Herwaarden, A. E., Gerretsen, J., Schambergen, R., Ruth, M. M., van der Hoeven, J. G., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0339oc · Cited by 177
An updated “norepinephrine equivalent” score in intensive care as a marker of shock severity
Kotani, Y., Gioia, A. D., Landoni, G., Belletti, A., & Khanna, A. K. (2023) · Critical Care · doi:10.1186/s13054-023-04322-y · Cited by 186

Authors: Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., Cook, D. J., Presneill, J. J., & Ayers, D.
Affiliations: St. Paul's Hospital (CA)
University of Ottawa (CA)
The Alfred Hospital (AU)
University of British Columbia (CA)
Mount Sinai Hospital (CA)
University of Toronto (CA)
McMaster University (CA)
The Royal Melbourne Hospital (AU)
ORCID: Russell, James A.
Walley, Keith R.
Singer, Joel
Gordon, Anthony C.
Hébert, Paul C.
Cooper, D. James
Holmes, Cheryl L.
Mehta, Sangeeta
Granton, John T.
Presneill, Jeffrey J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-02-28
Volume: 358
Issue: 9
Pages: 877-887
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa067373
OpenAlex: W2108153775
Cited by: 1,924
References: 36
Citations by year: 2026: 106 · 2025: 119 · 2024: 101 · 2023: 91 · 2022: 88 · 2021: 85 · 2020: 104 · 2019: 205 · 2018: 114 · 2017: 104 · 2016: 100 · 2015: 83 · 2014: 91 · 2013: 84 · 2012: 89
FWCI: 88.86
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
Keywords: septic shock, vasopressin, norepinephrine, vasopressor therapy, catecholamines, mortality, 28-day mortality, 90-day mortality, sepsis treatment, blood pressure support, adverse events, subgroup analysis
MeSH terms: Adult, Aged, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Norepinephrine, Severity of Illness Index, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Failure, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks